ArticleSensors (Basel, Switzerland)2025
Enhancing Medical Image Segmentation and Classification Using a Fuzzy-Driven Method.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Classification and Segmentation of Medical Images Using Cross-Representation Attention Fusion and Fuzzy Image Enhancement.Sensors (Basel, Switzerland) · 2026Article
- A New Encoding Architecture Based on Shift Multilayer Perceptron and Transformer for Medical Image Segmentation.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automated analysis for tumor segmentation and illness classification is hampered by the noise, low contrast, and ambiguity that are common in medical pictures. This work introduces a new 12-step fuzzy-based improvement pipeline that uses fuzzy entropy, fuzzy standard deviation, and histogram spread functions to enhance picture quality in CT, MRI, and X-ray modalities. The pipeline produces three improved versions per dataset, lowering BRISQUE scores from 28.8 to 21.7 (KiTS19), 30.3 to 23.4 (BraTS2020), and 26.8 to 22.1 (Chest X-ray). It is tested on KiTS19 (CT) for kidney tumor segmentation, BraTS2020 (MRI) for brain tumor segmentation, and Chest X-ray Pneumonia for classification. A Concatenated CNN (CCNN) uses the improved datasets to achieve a Dice coefficient of 99.60% (KiTS19, +2.40% over baseline), segmentation accuracy of 0.983 (KiTS19) and 0.981 (BraTS2020) versus 0.959 and 0.943 (CLAHE), and classification accuracy of 0.974 (Chest X-ray) versus 0.917 (CLAHE). A classic CNN is trained on original and CLAHE-filtered datasets. These outcomes demonstrate how well the pipeline works to improve image quality and increase segmentation/classification accuracy, offering a foundation for clinical diagnostics that is both scalable and interpretable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.